Funding Opportunities and Deadlines

Research Priority

Prevention

Letter of Intent Due

May 16

Neoepitopes in Type 1 Diabetes: Pathogenesis, Staging, and Therapeutic Utility

Details

Milestone Date Status
Letter of Intent May 16, 2019 Next
Application Jul 02, 2019
Award Notification Nov 30, 2019
Earliest Start Jan 01, 2020

Ongoing Opportunities

These funding sources are typically available annually or ongoing

Conference Grants

Industry Discovery & Development Partnerships

Early-Career Patient-Oriented Diabetes Research Awards (projects in COMPLICATIONS are ineligible)

Career Development Awards (projects in COMPLICATIONS are ineligible)

Advanced Postdoctoral Fellowships (projects in COMPLICATIONS are ineligible)

Postdoctoral Fellowships (projects in COMPLICATIONS are ineligible)

Project Concepts (Strategic Research Agreement)
Aug 01

RFAs Awaiting Notification

Apr

Identification of Areas of Artificial Pancreas Algorithm Enhancements Through Big-Data Analysis (Part 1)
Apr

Pilot Studies for Mechanisms of T1D Disease Pathogenesis
Apr

Beta Cell Replacement Innovative Grants
Apr

Beta Cell Regeneration and Survival Innovative Grants
May

Localized Immunomodulation in Beta Cell Replacement
May

Innovative Strategies To Demonstrate “Immunological Proof-of-Mechanism” And To Explore Early Outcome Measures In Immunotherapy Trials
Jun

JDRF National Diabetes Psychology Fellowship Program
Jun

Novel Adjunctive Therapeutic Strategies to Improve Metabolic Control in Type 1 Diabetes
Jul

Novel Pathways and Targets for Beta Cell Regenerating Therapies in Diabetes
Jul

Therapeutic Development and Early Clinical Testing of T Cell Targeted Immunotherapies for the Treatment of Type 1 Diabetes
Aug

No (Type) One Left Behind: Expanding Artificial Pancreas Adoption and Access Among Targeted Populations